Achieving international targets for tuberculosis treatment success among HIV-positive patients in New York City

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 12, 2010, Pages 1613-1620

  King, Liza ^a   Munsiff, S S ^a,b   Ahuja, S D ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Drug therapy; HIV TB co infection; HIV AIDS; Treatment success; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; RIFABUTIN; RIFAMPICIN;

ACID FAST BACTERIUM; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SHORT COURSE THERAPY; SPUTUM ANALYSIS; SPUTUM SMEAR; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUBERCULOSIS; UNITED STATES; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; DIRECTLY OBSERVED THERAPY; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; RETROSPECTIVE STUDIES; RIFABUTIN; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 78649340554     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. World Health Organization. 44th World Health Assembly: resolutions and decisions - resolution WHA 44.8. WHA44/1991/REC/1. Geneva, Switzerland: WHO, 1991.
2. World Health Organization, Stop TB Partnership. The Stop TB strategy 2006. WHO/HTM/STB/2006.37. Geneva, Switzerland: WHO, 2006.
3. Dye C, Maher D, Weil D, Espinal M, Raviglione M. Targets for global tuberculosis control. Int J Tuberc Lung Dis 2006; 10: 460-462.
4. Reid A, Scano F, Getahun H, et al. Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. Lancet Infect Dis 2006; 6: 483-495.
5. Corbett E L, Marston B, Churchyard G J, De Cock K M. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006; 367: 926-937.
6. El-Sony A I, Khamis A H, Enarson D A, Baraka O, Mustafa S A, Bjune G. Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection. Int J Tuberc Lung Dis 2002; 6: 1058-1066.
7. Harries A D, Nyangulu D S, Kang'ombe C, et al. Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi. Trans R Soc Trop Med Hyg 1998; 92: 343-347.
8. Campos R F, Munoz L F, Umbria D S, Mendez C, Nogales P M. [Outcome of treating initial tuberculosis in the area south of Seville in a 5-year period (1994-1998)]. Arch Bronconeumol 2001; 37: 177-183. [Spanish]
9. Daniel O J, Alausa O K. Treatment outcome of TB/HIV positive and TB/HIV negative patients on directly observed treatment, short course (DOTS) in Sagamu, Nigeria. Niger J Med 2006; 15: 222-226.
10. Murray J, Sonnenberg P, Shearer S C, Godfrey-Faussett P. H uman immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. Am J Respir Crit Care Med 1999; 159: 733-740.
11. Corbett E L, Watt C J, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009-1021.
12. Munsiff S S, Ahuja S D, King L, et al. Ensuring accountability: the contribution of the cohort review method to tuberculosis control in New York City. Int J Tuberc Lung Dis 2006; 10: 1133-1139.
13. New York City Department of Health and Mental Hygiene. Tuberculosis in New York City, 2005: annual summary. New York City, NY, USA: Department of Health and Mental Hygiene, 2006.
14. Girardi E, Antonucci G, Vanacore P, et al. Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS 2000; 14: 1985-1991.
15. Burman W J, Gallicano K D, Peloquin C A. Therapeutic implications of drug interactions in the treatment of human immunodefi ciency virus-related tuberculosis. Clin Infect Dis 1999; 28: 419-429.
16. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 2nd ed. WHO/TB/97.220. Geneva, Switzerland: WHO, 1997.
17. Bass J B Jr, Farer L S, Hopewell P C, et al. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society & The Centers for Disease Control and Prevention. Am J Respir Crit Care Med 1994; 149: 1359-1374.
18. Blumberg H M, Burman W J, Chaisson R E, et al. American Thoracic Society/Centers for Disease Control and Prevention/ Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-662.
19. Dean G L, Edwards S G, Ives N J, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 2002; 16: 75-83.
20. Burman W J, Jones B E. Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. Am J Respir Crit Care Med 2001; 164: 7-12.
21. Lawn S D, Myer L, Bekker L G, Wood R. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 2007; 21: 335-341.
22. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002; 359: 2059-2064.
23. Breen R A, Miller R F, Gorsuch T, et al. Virological response to highly active antiretroviral therapy is unaffected by antit uberculosis therapy. J Infect Dis 2006; 193: 1437-1440.
24. Hung C C, Chen M Y, Hsiao C F, Hsieh S M, Sheng W H, Chang S C. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy. AIDS 2003; 17: 2615-2622.
25. Makombe S D, Harries A D, Yu J K, et al. Outcomes of tuberculosis patients who start antiretroviral therapy under routine programme conditions in Malawi. Int J Tuberc Lung Dis 2007; 11: 412-416.
26. Westreich D, MacPhail P, Van R A, et al. Effect of pulmonary tuberculosis on mortality in patients receiving HAART. AIDS 2009; 23: 707-715.
27. King L, Ahuja S D, Munsiff S S. TB and HIV co-infection: current trends, diagnosis and treatment update. New York City Physician's Research Network. The PRN Notebook 2006; 11[2].
28. Harries A D, Libamba E, Schouten E J, Mwansambo A, Salaniponi F M, Mpazanje R. Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis. BMJ 2004; 329: 1163-1166.
29. World Health Organization. Report of a 'lessons learnt' workshop on the six ProTEST pilot projects in Malawi, South Africa and Zambia. WHO/HTM/STB/2004.336. Geneva, Switzerland: WHO, 2004.
30. Libamba E, Makombe S, Harries A D, et al. Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes - the case of Malawi. Int J Tuberc Lung Dis 2005; 9: 1062-1071.
31. World Health Organization. Guidelines for implementing collaborative TB and HIV programme activities. WHO/CDS/TB/ 2003.319. Geneva, Switzerland: WHO, 2003.
32. World Health Organization. Interim policy on collaborative TB/HIV activities. WHO/HTM/TB/2004. Geneva, Switzerland: WHO, 2004.
33. Bureau of Tuberculosis Control, New York City Department of Health & Mental Hygiene. Munsiff S S, Nilsen D, Ahuja S D, Burzynski J N. Antiretroviral drugs and the treatment of tuberculosis. New York, NY, USA: Department of Health & Mental Hygiene, 2007. http://www.nyc.gov/html/doh/downloads/pdf/chi/ chi25-4.pdf Accessed September 2010.
34. Munsiff S S, Fujiwara P I. Treatment of tuberculosis in patients taking antiretrovirals. The AIDS Reader 2000; 10: 102-108.
35. Panel on Antiretroviral Guidelines for Adults and Adolescents, New York City Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. New York, NY, USA: Department of Health and Human Services, 2009.